Iota Pharmaceuticals is Drug Discovery in United Kingdom that focus on drug design business. Founded in 2006. They cover business area such as operator, preclinical drug discovery, glioblastoma, antibacterial compound, novel mechanism, action, drug-resistant organism, structure-base drug design, property-base lead optimization, client, patent drug.
2006
( 18 years old in 2024 )
Drug Design
-
Saint Johns Innovation Centre
Cowley Road
Cambridge CB4 0WS
England, United Kingdom
Private
operatorpreclinical drug discoveryglioblastomaantibacterial compoundnovel mechanismactiondrug-resistant organismstructure-base drug designproperty-base lead optimizationclientpatent drug
* We use standard office opening hours in near Iota Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Iota Pharmaceuticals is Drug Discovery business from United Kingdom that founded in 2006 (18 years old in 2024), Iota Pharmaceuticals business is focusing on Drug Design.
Iota Pharmaceuticals headquarter office and corporate office address is located in Saint Johns Innovation Centre Cowley Road Cambridge CB4 0WS England, United Kingdom.
Iota Pharmaceuticals was founded in United Kingdom.
In 2024, Iota Pharmaceuticals is currently focus on drug design sector.
Above is snippet of Google Trends for "drug design" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Iota Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
